Publicacións en colaboración con investigadores/as de Massachusetts General Hospital (10)

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2019

  1. Genome-wide association study of white blood cell counts in patients with ischemic stroke

    Stroke, Vol. 50, Núm. 12, pp. 3618-3621

2013

  1. Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model

    Stroke, Vol. 44, Núm. 2, pp. 505-511

  2. Neuronal excitotoxicity after carotid angioplasty and stent placement procedures

    Radiology, Vol. 268, Núm. 2, pp. 515-520

2012

  1. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

    Clinical Science, Vol. 122, Núm. 3, pp. 113-119

  2. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  3. Neuroprotection or increased brain damage mediated by temperature in stroke is time dependent

    PLoS ONE, Vol. 7, Núm. 2

  4. Oxaloacetate: A novel neuroprotective for acute ischemic stroke

    International Journal of Biochemistry and Cell Biology

2010

  1. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: A systematic review

    Neurology, Vol. 75, Núm. 15, pp. 1333-1342